Clearside Biomedical, Inc. (CLSD): Stock Offering News

CLSD – Priced public offering of 6,538,462 shares of its common stock at $13.00/share.


Key Facts Surrounding This News Item


  • CLSD had a POWR Rating of A (Strong Buy) coming into today.
  • CLSD was 70.28% above its 10-Day Moving Average coming into today.
  • CLSD was 98.57% above its 20-Day Moving Average coming into today.
  • CLSD was 110.23% above its 50-Day Moving Average coming into today.
  • CLSD was 106.82% above its 100-Day Moving Average coming into today.
  • CLSD was 89.95% above its 200-Day Moving Average coming into today.
  • CLSD had returned +104.00% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About Clearside Biomedical, Inc. (CLSD)


Clearside Biomedical, a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. The company was founded in 2011 and is based in Alpharetta, Georgia View our full CLSD ticker page with ratings, news, and more.

CLSD at a Glance

CLSD Current POWR Rating™
Overall POWR Rating™
CLSD Current Price $1.35 1.46%
More CLSD Ratings, Data, and News

CLSD Price Reaction

The day of this event (Mar. 8, 2018)
CLSD Closing Price$13.00 8.96%
CLSD Volume5,725,900
2,087.51% from avg
Leading up to this event
CLSD 1-mo return154.09%
After this event
CLSD 1-day return9.85%
CLSD 3-day return14.88%
CLSD 5-day return21.22%

CLSD Price Chart


The Top Stocks For 2019

More Clearside Biomedical, Inc. (CLSD) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CLSD News
Page generated in 0.8865 seconds.